CA2803865A1 - Procedes de detection de cancer - Google Patents

Procedes de detection de cancer Download PDF

Info

Publication number
CA2803865A1
CA2803865A1 CA2803865A CA2803865A CA2803865A1 CA 2803865 A1 CA2803865 A1 CA 2803865A1 CA 2803865 A CA2803865 A CA 2803865A CA 2803865 A CA2803865 A CA 2803865A CA 2803865 A1 CA2803865 A1 CA 2803865A1
Authority
CA
Canada
Prior art keywords
tag
pmg
bmp
dag
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2803865A
Other languages
English (en)
Inventor
Teresa Whei-Mei Fan
Andrew Nicholas Lane
Richard M. Higashi
Michael Bousamra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Louisville Research Foundation ULRF
Original Assignee
University of Louisville Research Foundation ULRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Louisville Research Foundation ULRF filed Critical University of Louisville Research Foundation ULRF
Publication of CA2803865A1 publication Critical patent/CA2803865A1/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention porte sur des procédés qui permettent de déterminer l'absence ou la présence d'un ou de plusieurs types de cancer chez un animal. Dans certains modes de réalisation, des quantités de lipides dans un échantillon (par exemple un liquide organique ou un traitement de celui-ci) provenant de l'animal sont utilisées avec un modèle prédictif pour effectuer la détermination. Les quantités de lipides peuvent être mesurées, dans certains cas, à l'aide d'un système de spectrométrie de masse.
CA2803865A 2010-06-23 2011-06-22 Procedes de detection de cancer Pending CA2803865A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35764210P 2010-06-23 2010-06-23
US61/357,642 2010-06-23
PCT/US2011/041399 WO2011163332A2 (fr) 2010-06-23 2011-06-22 Procédés de détection de cancer

Publications (1)

Publication Number Publication Date
CA2803865A1 true CA2803865A1 (fr) 2011-12-29

Family

ID=45372067

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2803865A Pending CA2803865A1 (fr) 2010-06-23 2011-06-22 Procedes de detection de cancer

Country Status (8)

Country Link
US (2) US20130109592A1 (fr)
EP (4) EP2585833B1 (fr)
JP (3) JP5944385B2 (fr)
AU (3) AU2011270968C1 (fr)
CA (1) CA2803865A1 (fr)
DK (1) DK2585833T3 (fr)
ES (2) ES2812457T3 (fr)
WO (1) WO2011163332A2 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012343843B2 (en) * 2011-11-30 2018-03-08 Metanomics Health Gmbh Device and methods to diagnose pancreatic cancer
ES2690829T3 (es) 2012-09-17 2018-11-22 Agios Pharmaceuticals, Inc. Uso de e-cadherina y vimentina para la selección de pacientes que responden al tratamiento
AU2013347933C1 (en) 2012-11-21 2018-10-04 Agios Pharmaceuticals, Inc. Glutaminase inhibitors and methods of use
US9029531B2 (en) 2012-11-22 2015-05-12 Agios Pharmaceuticals, Inc. Compounds and their methods of use
WO2014079011A1 (fr) 2012-11-22 2014-05-30 Agios Pharmaceuticals, Inc. Composés hétérocycliques pour inhiber la glutaminase et procédés d'utilisation de ceux-ci
WO2014116856A1 (fr) * 2013-01-24 2014-07-31 The Regents Of The University Of California Utilisation de particules de lipide dans des diagnostics médicaux
KR101408217B1 (ko) * 2013-05-22 2014-06-17 국립암센터 질량분석패턴을 이용한 원발성간내담도암 및 전이성간암의 감별법
EP3084443B1 (fr) * 2013-12-20 2018-08-22 Metanomics Health GmbH Moyens et méthodes pour diagnostiquer un cancer du pancréas chez un sujet sur la base d'un panneau de métabolite
CA2943339A1 (fr) 2014-03-21 2015-09-24 Agios Pharmaceuticals, Inc. Composes et procedes d'utilisation desdits composes
MX2015008690A (es) * 2014-07-04 2016-02-03 Tata Consultancy Services Ltd Sistema y procedimiento para análisis prescriptivos.
US10758133B2 (en) * 2014-08-07 2020-09-01 Apple Inc. Motion artifact removal by time domain projection
EP3427066A4 (fr) * 2016-03-10 2020-02-19 Agency for Science, Technology and Research Biomarqueurs lipidiques destinés au diagnostic du cancer
JP6520893B2 (ja) 2016-04-01 2019-05-29 株式会社デンソー 運転支援装置及び運転支援プログラム
KR101812205B1 (ko) * 2016-04-11 2017-12-26 연세대학교 산학협력단 혈청 대사체를 이용한 인후암 예측 방법
WO2018013678A2 (fr) * 2016-07-13 2018-01-18 Board Of Regents, The University Of Texas System Marqueurs moléculaires et procédés d'analyse d'échantillons par spectrométrie de masse
US10643832B2 (en) 2016-09-02 2020-05-05 Board Of Regents, The University Of Texas System Collection probe and methods for the use thereof
CA2964878A1 (fr) * 2016-10-14 2018-04-14 Youping Deng Marqueurs lipidiques de diagnostic precoce de cancer du sein
US20180246112A1 (en) * 2017-02-28 2018-08-30 University Of Kentucky Research Foundation Biomarkers of Breast and Lung Cancer
US20200173997A1 (en) * 2017-05-11 2020-06-04 Servizo Galego De Saúde (Sergas) Cholesteryl linoleate (18:2) in feces samples as biomarker for colorectal cancer
WO2019104328A1 (fr) 2017-11-27 2019-05-31 Board Of Regents, The University Of Texas System Sonde de collecte à degré d'invasion minimal et son procédé d'utilisation
JP7086417B2 (ja) * 2018-01-22 2022-06-20 ウニベルシタ パルドゥビツェ 体液のリピドミクス解析に基づいて癌を診断する方法
ES2841950T3 (es) * 2018-01-22 2021-07-12 Univ Pardubice Un procedimiento de diagnóstico de cáncer pancreático en base al análisis lipidómico de un fluido corporal
CN109613131B (zh) * 2018-11-27 2021-08-27 北京大学第三医院 基于尿液磷脂组学的肾损伤早期诊断标志物及应用
KR102156217B1 (ko) * 2019-03-05 2020-09-15 연세대학교 산학협력단 대장암 진단용 지질 바이오마커 및 이의 용도
KR102156216B1 (ko) * 2019-03-05 2020-09-15 연세대학교 산학협력단 위암 진단용 지질 바이오마커 및 이의 용도
KR102156215B1 (ko) * 2019-03-05 2020-09-15 연세대학교 산학협력단 갑상선암 진단용 지질 바이오마커 및 이의 용도
KR102156214B1 (ko) * 2019-03-05 2020-09-15 연세대학교 산학협력단 폐암 진단용 지질 바이오마커 및 이의 용도
KR102421466B1 (ko) * 2021-10-06 2022-07-18 (주)이노베이션바이오 암 진단용 바이오마커 및 이의 용도
CN117233367B (zh) * 2023-11-16 2024-02-09 哈尔滨脉图精准技术有限公司 妊娠期高血压风险评估的代谢标志物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824555A (en) * 1996-05-30 1998-10-20 The Cleveland Clinic Foundation Method of detecting gynecological carcinomas
IL131985A0 (en) * 1997-03-21 2001-03-19 Atairgin Biotechnologies Inc Method for detecting cancer associated with altered concentrations of lysophospholipids
US7964408B1 (en) * 2004-05-13 2011-06-21 University Of South Florida Lysophospholipids as biomarkers of ovarian cancer
WO2006044680A1 (fr) * 2004-10-14 2006-04-27 The Cleveland Clinic Foundation Procedes de detection de cancer colorectal
US8409794B2 (en) * 2006-03-24 2013-04-02 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
US9213030B2 (en) * 2008-01-28 2015-12-15 National University Of Singapore Lipid tumour profile
CN102105598A (zh) * 2008-06-20 2011-06-22 代理生命科学控股公司 基于微泡的组合物和方法
EA201201085A1 (ru) * 2010-02-11 2013-05-30 Католиеке Иниверситейт Леувен Фосфолипидное профилирование и рак

Also Published As

Publication number Publication date
ES2812457T3 (es) 2021-03-17
DK2585833T3 (en) 2017-09-18
JP5944385B2 (ja) 2016-07-05
EP3719502A1 (fr) 2020-10-07
EP3955004A2 (fr) 2022-02-16
US20130109592A1 (en) 2013-05-02
JP2013529784A (ja) 2013-07-22
EP3206034A3 (fr) 2017-10-11
WO2011163332A2 (fr) 2011-12-29
EP3955004B1 (fr) 2024-05-29
US20220003792A1 (en) 2022-01-06
WO2011163332A9 (fr) 2012-04-26
EP3206034B1 (fr) 2020-05-27
ES2638522T8 (es) 2021-02-11
EP3955004A3 (fr) 2022-05-11
AU2011270968A1 (en) 2013-01-24
EP2585833A4 (fr) 2013-11-13
EP2585833B1 (fr) 2017-05-31
AU2016213855B2 (en) 2018-07-05
JP2015158512A (ja) 2015-09-03
EP3206034A2 (fr) 2017-08-16
AU2016213855A1 (en) 2016-09-01
JP2016218085A (ja) 2016-12-22
AU2011270968C1 (en) 2017-01-19
AU2018236876A1 (en) 2018-10-18
ES2638522T3 (es) 2017-10-23
EP2585833A2 (fr) 2013-05-01
JP6092302B2 (ja) 2017-03-08

Similar Documents

Publication Publication Date Title
US20220003792A1 (en) Methods related to cancer
AU2011270968B2 (en) Methods for detecting cancer
CN107580675B (zh) 拭子和活检样品的快速蒸发电离质谱（“reims”）和解吸电喷雾电离质谱（“desi-ms”）分析
Woolman et al. Rapid determination of medulloblastoma subgroup affiliation with mass spectrometry using a handheld picosecond infrared laser desorption probe
CN112557490A (zh) 拭子和活检样品的快速蒸发电离质谱和解吸电喷雾电离质谱分析
Williams et al. HMGA1 drives metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis
Arendowski et al. Screening of urinary renal cancer metabolic biomarkers with gold nanoparticles-assisted laser desorption/ionization mass spectrometry
Wang et al. Lipidomics profiling of myelin
US11353467B2 (en) Use of lipid particles in medical diagnostics
Zhang et al. Altered phosphatidylcholines expression in sputum for diagnosis of non-small cell lung cancer
EP2210107A1 (fr) Procédés pour détecter ou surveiller un cancer à l'aide de lpc en tant que marqueur
Cao et al. A metabonomics study of Chinese miniature pigs with acute liver failure treated with transplantation of placental mesenchymal stem cells
Leopold et al. Visualizing phosphatidylcholine via mass spectrometry imaging: relevance to human health
CN116183922B (zh) 口腔鳞状细胞癌诊断模型的构建方法、标志物及其应用
US20220065863A1 (en) Predictive biomarkers for adverse effects of radiation therapy
Shaheed Oncoproteomic applications for detection of breast cancer. Proteomic profiling of breast cancer models and biopsies
Gonzalez-Riano et al. LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation
Bailey Molecular Biological Changes in a Rabbit Model of Vocal Fold Dehydration
Mittal Molecular Characterization of Metastatic Endometrial Cancer by Mass Spectrometry
Corbo CHARACTERIZATION OF PROTEINS INVOLVED IN INTRACELLULAR PATHWAYS OF COLON CANCER STEM CELLS
Gathercole Biomarker discovery for pre-clinical diagnosis of Tasmanian devil facial tumour disease
Telu Development of Mass Spectrometric Methods for Biomarker Discovery

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517

EEER Examination request

Effective date: 20160517